Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Juan Carlos Rejon-Parrilla"'
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Introduction: Advanced Therapy Medicinal Products are a type of therapies that, in some cases, hold great potential for patients without an effective current therapeutic approach but they also present multiple challenges to payers. While there are ma
Externí odkaz:
https://doaj.org/article/31e19f289e864cbba9290ea03a90ef4d
Publikováno v:
Health Economics Review, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract Background What constitutes innovation in health technologies can be defined and measured in a number of ways and it has been widely researched and published about. However, while many countries mention it as a criterion for pricing or reimb
Externí odkaz:
https://doaj.org/article/8a264936fb494e25ae797d47d028415a
Autor:
John Brazier, Tessa Peasgood, Clara Mukuria, Ole Marten, Simone Kreimeier, Nan Luo, Brendan Mulhern, A. Simon Pickard, Federico Augustovski, Wolfgang Greiner, Lidia Engel, Maria Belizan, Zhihao Yang, Andrea Monteiro, Maja Kuharic, Luz Gibbons, Kristina Ludwig, Jill Carlton, Janice Connell, Stacey Rand, Nancy Devlin, Karen Jones, Aki Tsuchiya, Rosemary Lovett, Bhash Naidoo, Donna Rowen, Juan Carlos Rejon-Parrilla
Objectives\ud \ud Existing measures for estimating quality-adjusted life-years are mostly limited to health-related quality of life. This article presents an overview of the development the EQ-HWB (EQ Health and Wellbeing), which is a measure that en
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::171f36bf7285b02d5761c1ed1cb3521b
https://hdl.handle.net/10453/163274
https://hdl.handle.net/10453/163274
Autor:
Maximilian Salcher-Konrad, Jacoline C. Bouvy, Karen Facey, Chiara de Waure, Jaime Espín, Seamus Kent, Juan Carlos Rejon-Parrilla, Stefania Boccia, Pall Jonsson, Mary Nguyen
Publikováno v:
Kent, S, Salcher-Konrad, M, Boccia, S, Bouvy, J C, Waure, C D, Espin, J, Facey, K, Nguyen, M, Rejon, J C & Jonsson, P 2021, ' The use of nonrandomized evidence to estimate treatment effects in health technology assessment ', Journal of comparative effectiveness research . https://doi.org/10.2217/cer-2021-0108
Health technology assessment (HTA) is increasingly informed by nonrandomized studies, but there is limited guidance from HTA bodies on expectations around evidence quality and study conduct. We developed recommendations to support the appropriate use
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f443131f6da425db90452edb3e1d696
https://www.pure.ed.ac.uk/ws/files/219819234/The_use_of_nonrandomized_evidence_to_estimate_treatment_effects_in_health_technology_assessment.pdf
https://www.pure.ed.ac.uk/ws/files/219819234/The_use_of_nonrandomized_evidence_to_estimate_treatment_effects_in_health_technology_assessment.pdf
Autor:
Rosemary Lovett, John Brazier, Bhash Naidoo, Janice Connell, Juan Carlos Rejon-Parrilla, Stacey Rand, Karen C. Jones, Clara Mukuria, Tessa Peasgood, Nancy Devlin, Jill Carlton, Aki Tsuchiya, Donna Rowen
Publikováno v:
The European Journal of Health Economics
Economic evaluation combines costs and benefits to support decision-making when assessing new interventions using preference-based measures to measure and value benefits in health or health-related quality of life. These health-focused instruments ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d184b96c21148fe7761d4cbcb5b416cd
https://kar.kent.ac.uk/87816/2/Peasgood2021_Article_WhatIsTheBestApproachToAdoptFo.pdf
https://kar.kent.ac.uk/87816/2/Peasgood2021_Article_WhatIsTheBestApproachToAdoptFo.pdf
Publikováno v:
Br J Clin Pharmacol
In 2016, the European Medicines Agency published the conclusions of its pilot on adaptive pathways, with products in early stages of development still building up to their marketing authorisation. Adaptive pathways rests on three principles: iterativ
Autor:
Huseyin Naci, Pall Jonsson, Maximilian Salcher-Konrad, K Davis, Juan Carlos Rejon-Parrilla, M Nguyen
Publikováno v:
European Journal of Public Health. 29
Background Increasingly, health technology assessment (HTA) agencies must decide whether new medicines should be used routinely in the absence of randomised controlled trial (RCT) data, relying solely on non-randomised studies (NRS), which are at hig
Autor:
James Love-Koh, Alison Peel, Matthew Taylor, Hannah Wood, Kate Ennis, Anastasia Chalkidou, Rosemary Lovett, Juan Carlos Rejon-Parrilla, Andrea Manca
Publikováno v:
Pharmacoeconomics
Objective Precision medicine allows healthcare interventions to be tailored to groups of patients based on their disease susceptibility, diagnostic or prognostic information, or treatment response. We analysed what developments are expected in precis
Autor:
Michelle Jenks, Moni Choudhury, Alison Peel, Juan Carlos Rejon-Parrilla, Andrew Sims, Rosemary Lovett, Joyce Craig
Publikováno v:
Applied Health Economics and Health Policy
Objectives This study aimed to review current use of experts within National Institute for Health and Care Excellence (NICE) guidance-making programmes, identify improvements in use of expert judgement, and to assess tools and protocols to support th
Autor:
Alison Peel, Michelle Jenks, Moni Choudhury, Rosemary Lovett, Juan Carlos Rejon‑Parrilla, Andrew Sims, Joyce Craig
Publikováno v:
Applied Health Economics and Health Policy. 17:263-264